Remedium Bio

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

Undisclosed

Remedium Bio is a biotechnology company specializing in gene therapy, developing an adjustable-dose GLP-1 receptor agonist for superior weight loss and glycemic control as a safer, cost-effective alternative to traditional treatments.

Total Funding

Undisclosed

Headquarters

Norwalk, USA

Founded

N/A

Website

remedium-bio.com

Focus Areas

gene therapy

GLP-1 receptor agonist

weight loss

glycemic control

insulin response

adjustable-dose

Investors